Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,576.20
(
-0.46%
)
US TECH 100
23,643.60
(
-0.33%
)
Dow Jones
45,878.73
(
-0.31%
)
Brent Oil
105.64
(
1.15%
)
Bitcoin
70,085.62
(
0.27%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

flatlander_60048

Send PM Follow Ignore
Followers 10
Posts 480
Boards Moderated 0
Alias Born 02/10/2006

flatlander_60048

Re: DewDiligence post# 92760

Friday, 03/19/2010 10:40:30 PM

Friday, March 19, 2010 10:40:30 PM

Post# of 257262
Teva indicates it is more concerned about new oral treatments entering the MS market. Either way I think NVS is positioned to challenge Copaxone.

How do you handicap the odds that FTY720 gets approved in 2010.

FL
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now